Peritoneal Cancer
141
18
31
74
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
39 trials with published results (28%)
Research Maturity
74 completed trials (52% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
9.9%
14 terminated out of 141 trials
84.1%
-2.5% vs benchmark
11%
16 trials in Phase 3/4
53%
39 of 74 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 74 completed trials
Clinical Trials (141)
TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE)
A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)
A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
Using Aspirin to Improve Immunological Features of Ovarian Tumors
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
Genomic BRCA and Extensive ovArian Cancer Testing
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery
A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib
Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma
Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases
The PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilot Study.
Depression Treatment and Screening in Ovarian Cancer Patients
Choices About Genetic Testing And Learning Your Risk With Smart Technology
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes